A wearable, artificial intelligence (AI)-driven, continuous-use transcutaneous peripheral nerve stimulation (TPNS) device was linked to significant improvement in upper limb tremor in adult patients ...

BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...

Parkinson's disease is considered a movement disorder, so it lends itself quite well to mobile technologies. At least one tablet-based device to measure Parkinsonian tremors is already on the market, ...

Scientists have developed a biorobotic arm that can mirror human tremors, such as those experienced by individuals that live with Parkinson's disease. Artificial muscles on either side of the forearm ...

A busy, stimulating convention like CES can exacerbate hand tremors for those living with Parkinson's Disease. For Roberta Wilson-Garrett, however, a new wearable device has been helping keep the ...

It is estimated that around 80 million people worldwide live with a tremor. For example, those who live with Parkinson's disease. The involuntary periodic movements sometimes strongly affect how ...

The US Food and Drug Administration (FDA) has cleared Encora Therapeutics’ neurostimulation wearable for essential tremor (ET) management. The Massachusetts-based company’s Encora X1 is a wrist-worn ...

Researchers have developed a highly accurate, explainable machine learning model that can differentiate between essential tremor (ET) and cortical myoclonus (CM) using wearable sensor data. A new ...

Propranolol and Primidone demonstrate efficacy in up to 70% of patients as first-line agents. MR-Guided Focused Ultrasound (MRgFUS) results in approximately 56% tremor reduction at 4 years. Deep Brain ...